Accessibility Menu
 
Celularity logo

Celularity

(NASDAQ) CELU

Current Price$0.87
Market Cap$25.19M
Since IPO (2019)-99%
5 Year-99%
1 Year-65%
1 Month-26%

Celularity Financials at a Glance

Market Cap

$25.19M

Revenue (TTM)

$26.55M

Net Income (TTM)

$91.71M

EPS (TTM)

$-3.58

P/E Ratio

-0.24

Dividend

$0.00

Beta (Volatility)

1.34 (Average)

Price

$0.87

Volume

120,929.195

Open

$0.88

Previous Close

$0.87

Daily Range

$0.84 - $0.92

52-Week Range

$0.71 - $4.35

CELU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Celularity

Industry

Biotechnology

Employees

115

CEO

Robert Joseph Hariri Gordon, MD, PhD

Headquarters

Florham Park, NJ 07932, US

CELU Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

-2%

Net Income Margin

-3%

Return on Equity

-6367%

Return on Capital

-2%

Return on Assets

-85%

Earnings Yield

-4.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.19M

Shares Outstanding

28.95M

Volume

120.93K

Avg. Volume

203.42K

Financials (TTM)

Gross Profit

$20.19M

Operating Income

$61.31M

EBITDA

$77.66M

Operating Cash Flow

$13.25M

Capital Expenditure

$0.00

Free Cash Flow

$13.25M

Cash & ST Invst.

$6.17M

Total Debt

$40.90M

Celularity Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.10M

-77.4%

Gross Profit

$8.56M

-20.7%

Gross Margin

2.08%

N/A

Market Cap

$25.19M

N/A

Market Cap/Employee

$209.88K

N/A

Employees

120

N/A

Net Income

$24.36M

-83.3%

EBITDA

$21.66M

-185.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$34.73M

+49.0%

Accounts Receivable

$4.65M

-65.7%

Inventory

$571.00K

-89.4%

Long Term Debt

$26.90M

-56.9%

Short Term Debt

$14.00M

+120.1%

Return on Assets

-85.45%

N/A

Return on Invested Capital

-2.31%

N/A

Free Cash Flow

$5.10M

-431.8%

Operating Cash Flow

$5.10M

-420.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BTAIBioXcel Therapeutics, Inc.
$1.13-0.88%
GBIOGeneration Bio Co.
$5.34+0.00%
FGENFibroGen, Inc.
$9.07-1.63%
TPSTTempest Therapeutics, Inc.
$1.86+2.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
RGTIRigetti Computing
$26.42+0.20%
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%

Questions About CELU

What is the current price of Celularity?

Celularity is trading at $0.87 per share.

What is the 52-week range for Celularity?

Over the past 52 weeks, Celularity has traded between $0.71 and $4.35.

How much debt does Celularity have?

As of the most recent reporting period, Celularity reported total debt of $74.71M.

How much cash does Celularity have on hand?

Celularity reported $6.17M in cash and cash equivalents in its most recent financial results.

What is Celularity’s dividend yield?

Celularity does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.